Literature DB >> 9770116

The erbB2 gene as a cancer therapeutic target and the tumor- and metastasis-suppressing function of E1A.

D Yu1, M C Hung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9770116     DOI： 10.1023/a:1006054421970

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  5 in total

1.  p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing.

Authors:  M B Flinterman; J S Mymryk; P Klanrit; A F Yousef; S W Lowe; C Caldas; J Gäken; F Farzaneh; M Tavassoli
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

2.  FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.

Authors:  Jen-Liang Su; Xiaoyun Cheng; Hirohito Yamaguchi; Yi-Wen Chang; Chao-Feng Hou; Dung-Fang Lee; How-Wen Ko; Kuo-Tai Hua; Ying-Nai Wang; Michael Hsiao; Poshen B Chen; Jung-Mao Hsu; Robert C Bast; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2011-09-12       Impact factor: 12.701

3.  A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.

Authors:  Xiaoming Xie; Jennifer L Hsu; Min-Gew Choi; Weiya Xia; Hirohito Yamaguchi; Chun-Te Chen; Bon Q Trinh; Zhen Lu; Naoto T Ueno; Judith K Wolf; Robert C Bast; Mien-Chie Hung
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

4.  A novel role mediated by adenoviral E1A in suppressing cancer through modulating decorin.

Authors:  Yan Ge; Wen Zhang; Jing Qin; Chen Zhang; Weiping Tian; Qi Zhang; Jie Shao; Shasha Li; Lin Fang; Junnian Zheng
Journal:  Med Oncol       Date:  2019-10-28       Impact factor: 3.064

5.  A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer.

Authors:  Chih-Ming Su; Ting-Yu Chang; Hui-Ping Hsu; Hui-Huang Lai; Jie-Ning Li; Yu-Jhen Lyu; Kuang-Tai Kuo; Ming-Te Huang; Jen-Liang Su; Pai-Sheng Chen
Journal:  Oncotarget       Date:  2016-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.